retatrutide type 2 diabetes phase 2 trial results Weight loss with as compared to currently licenced obesity Perceived benefits of treatment for
Description
Convenient Dosing
Wondering whether GLP-1 is a lifelong commitment
Based on these findings, we anticipate that women will continue to be disproportionately impacted by the adverse effects associated with all members of this drug class
Clinical Trial Evidence (Phase 3)
Nausea is the most common side effect of semaglutide, which is available by the brand names Ozempic, Wegovy, and Rybelsus
